BLCM - ベリカム・ファ―マシュ―ティカルズ (Bellicum Pharmaceuticals Inc.) ベリカム・ファ―マシュ―ティカルズ

 BLCMのチャート


 BLCMの企業情報

symbol BLCM
会社名 Bellicum Pharmaceuticals Inc (ベリカム・ファ―マシュ―ティカルズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 ベリカム・ファーマスーティカルズ(Bellicum Pharmaceuticals Inc)は臨床段階のバイオ医薬品会社である。同社は血液癌、固形癌とオーファン遺伝性血液疾患等の癌の細胞免疫療法の発見・開発に従事する。同社は二量体化学誘導(CID)技術プラットフォームによって、免疫系のコンポーネントの設計・制御を行う。同社は造血幹細胞移植(HSCT)、キメラ抗原レセプター(CAR)T細胞療法とT細胞レセプター(TCR)細胞療法等の細胞免疫療法分野の次世代製品候補の開発を行う。同社の製品はBPX-501、BPX-601、BPX-701を含む。CIDベースの技術はCaspaCIDe、GoCAR-Tを含む。同社は米国とヨーロッパにある白血病、リンパ腫と遺伝性血液疾患を有する成人・小児患者の第一または第二臨床試験への評価を行う。   ベリカム・ファ―マシュ―ティカルズは、米国の新興バイオ医薬品会社。癌の免疫療法やワクチンの発見や開発に注力する。また、「CaspaCIDe」という細胞のアポト―シス(細胞死)を誘導する仕組みを利用した自殺遺伝子に関する技術を保有する。本社は、テキサス州ヒュ―ストン。   
本社所在地 2130 W. Holcombe Blvd. Ste. 800 Houston TX 77030 USA
代表者氏名 James Farrell Brown ジェームスファレルブラウン
代表者役職名 Independent Chairman of the Board
電話番号 +1 832-384-1100
設立年月日 38169
市場名 NASDAQ National Market System
ipoyear 2014年
従業員数 137人
url www.bellicum.com
nasdaq_url https://www.nasdaq.com/symbol/blcm
adr_tso
EBITDA EBITDA(百万ドル) -82.70400
終値(lastsale) 5.8
時価総額(marketcap) 251424234.8
時価総額 時価総額(百万ドル) 296.70810
売上高 売上高(百万ドル) 0.57300
企業価値(EV) 企業価値(EV)(百万ドル) 202.86210
当期純利益 当期純利益(百万ドル) -92.36400
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Bellicum Pharmaceuticals Inc revenues increased from $128K to $516K. Net loss increased 1% to $47M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research_Development Expense increase of 5% to $31.7M (expense) Stock-based Compensation in SGA increase of 11% to $3.9M (expense).

 BLCMのテクニカル分析


 BLCMのニュース

   88 Biggest Movers From Friday  2021/02/01 09:07:57 Benzinga
Gainers Siebert Financial Corp. (NASDAQ: SIEB ) shares climbed 121.6% to close at $8.22 on Friday on heavy volume. Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB ) climbed 70.8% to close at $4.15 after the company announced the acquisition of Quellis Biosciences. GameStop Corp. (NYSE: GME ) shares added 67.9% to close at $325.00 after Robinhood said it would allow some buying of the stocks on Friday after sparking outrage over discontinuing purchases of GME, AMC, and high stocks seeing social media interest. The company’s stock dropped over 44% on Thursday. Novavax, Inc. (NASDAQ: NVAX ) surged 64.9% to close at $220.94 after the company said Thursday that its COVID-19 vaccine candidate NVX-COV2373 showed 89.3% efficacy in Phase 3 trials conducted in the United Kingdom. AMC Entertainment Holdings, Inc. (NYSE: AMC ) surged 53.7% to close at $13.26 after Robinhood said it would allow some buying of the stocks on Friday after sparking outrage over discontinuing purchases of GME, AMC, and high stocks seeing social media interest.
   Amid a record bad year, Bellicum keeps taking its lumps as FDA slams trial hold on CAR-T hopeful  2020/12/07 13:55:19 Endpoints News
It’s been no less than a disastrous year for Houston biotech Bellicum Pharmaceuticals after taking a scalpel to its pipeline and dumping a vast majority of its staff. Now, in an already-doomed trial of one of Bellicum’s next-gen oncology hopefuls, the FDA is doling out even more lumps. Bellicum divulged
   Recent Updates on Hemophagocytic Lymphohistiocytosis Market 2020-2027, Global Players are SOBI, AB2 Bio Ltd, Alpine Immune Sciences, Bellicum Pharmaceuticals  2020/11/18 12:21:10 OpenPR
Global Hemophagocytic Lymphohistiocytosis Market report brings into light key market dynamics of the sector. It provides guidelines about planning of advertising and sales promotion efforts. The market report is a professional yet exhaustive study on the current state for the
   The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies  2020/11/10 13:40:14 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 9) Alcon AG (NYSE: ALC ) Aligos Therapeutics Inc (NASDAQ: ALGS ) Aptevo Therapeutics Inc (NASDAQ: APVO ) (announced second complete remission in a patient in Cohort 6 of a Phase 1 study of AVO436 in acute myeloid leukemia and myelodysplastic syndrome patients) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) BIO-TECHNE Corp (NASDAQ: TECH ) BioLife Solutions Inc (NASDAQ: BLFS ) BioNTech SE – ADR (NASDAQ: BNTX ) - announced over 90% efficacy in the Phase 3 study of its coronavirus vaccine candidate co-developed with Pfizer Inc. (NYSE: PFE ) C4 Therapeutics Inc (NASDAQ: CCCC ) Calliditas Therapeutics Adr Rep 2 Ord Shs (NASDAQ: CALT ) (announced positive topline results from Part A of the Phase 3 clinical trial of Nefecon in patients with primary IgA nephropathy) Catalent Inc (NYSE: CTLT ) Denali Therapeutics Inc (NASDAQ: DNLI ) Fate Therapeutics Inc (NASDAQ: FATE ) Halozyme Therapeutics, Inc.
   The Daily Biotech Pulse: Alzheimer's Conference Underway, Biogen's Aducanumab Briefing Doc, Supernus Earnings  2020/11/04 13:21:27 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 3) Bio-Rad Laboratories, Inc. (NYSE: BIO ) Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN ) BioLife Solutions Inc (NASDAQ: BLFS ) BioLineRx ADR Representing 15 Ord Shs (NASDAQ: BLRX )(reacted to positive readout for its stem cell therapy to treat cancer) Halozyme Therapeutics, Inc. (NASDAQ: HALO )(reacted to its quarterly results) Idera Pharmaceuticals Inc (NASDAQ: IDRA ) Inspire Medical Systems Inc (NYSE: INSP ) ( reported strong results for the third quarter) Immunovant Inc (NASDAQ: IMVT ) Scholar Rock Holding Corp (NASDAQ: SRRK ) Ultragenyx Pharmaceutical Inc (NASDAQ: RARE ) United Therapeutics Corporation (NASDAQ: UTHR ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Nov. 3) Abeona Therapeutics Inc (NASDAQ: ABEO ) Aprea Therapeutics Inc (NASDAQ: APRE ) Bellicum Pharmaceuticals Inc (NASDAQ: BLCM ) Benitec Biopharma Inc (NASDAQ: BNTC ) Esperion Therapeutics Inc (NASDAQ: ESPR ) (reacted to its quarterly results) Happiness Biotech Group Ltd (NASDAQ: HAPP ) Jaguar Health Inc (NASDAQ: JAGX ) Liminal BioSciences Inc (NASDAQ: LMNL ) Nabriva Therapeutics PLC – ADR (NASDAQ: NBRV ) Neovasc Inc (NASDAQ: NVCN ) Opthea Spon (NASDAQ: OPT ) Silence Therapeutics ADR (NASDAQ: SLN ) Titan Pharmaceuticals, Inc (NASDAQ: TTNP ) Stocks In Focus Bristol-Myers Squibb Says Antitrust Waiting Period For Proposed Myokardia Acquisition Expires Bristol-Myers Squibb Co (NYSE: BMY ) said the waiting period under the HSR Act in connection with its previously announced tender offer to acquire …
   88 Biggest Movers From Friday  2021/02/01 09:07:57 Benzinga
Gainers Siebert Financial Corp. (NASDAQ: SIEB ) shares climbed 121.6% to close at $8.22 on Friday on heavy volume. Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB ) climbed 70.8% to close at $4.15 after the company announced the acquisition of Quellis Biosciences. GameStop Corp. (NYSE: GME ) shares added 67.9% to close at $325.00 after Robinhood said it would allow some buying of the stocks on Friday after sparking outrage over discontinuing purchases of GME, AMC, and high stocks seeing social media interest. The company’s stock dropped over 44% on Thursday. Novavax, Inc. (NASDAQ: NVAX ) surged 64.9% to close at $220.94 after the company said Thursday that its COVID-19 vaccine candidate NVX-COV2373 showed 89.3% efficacy in Phase 3 trials conducted in the United Kingdom. AMC Entertainment Holdings, Inc. (NYSE: AMC ) surged 53.7% to close at $13.26 after Robinhood said it would allow some buying of the stocks on Friday after sparking outrage over discontinuing purchases of GME, AMC, and high stocks seeing social media interest.
   Amid a record bad year, Bellicum keeps taking its lumps as FDA slams trial hold on CAR-T hopeful  2020/12/07 13:55:19 Endpoints News
It’s been no less than a disastrous year for Houston biotech Bellicum Pharmaceuticals after taking a scalpel to its pipeline and dumping a vast majority of its staff. Now, in an already-doomed trial of one of Bellicum’s next-gen oncology hopefuls, the FDA is doling out even more lumps. Bellicum divulged
   Recent Updates on Hemophagocytic Lymphohistiocytosis Market 2020-2027, Global Players are SOBI, AB2 Bio Ltd, Alpine Immune Sciences, Bellicum Pharmaceuticals  2020/11/18 12:21:10 OpenPR
Global Hemophagocytic Lymphohistiocytosis Market report brings into light key market dynamics of the sector. It provides guidelines about planning of advertising and sales promotion efforts. The market report is a professional yet exhaustive study on the current state for the
   The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies  2020/11/10 13:40:14 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 9) Alcon AG (NYSE: ALC ) Aligos Therapeutics Inc (NASDAQ: ALGS ) Aptevo Therapeutics Inc (NASDAQ: APVO ) (announced second complete remission in a patient in Cohort 6 of a Phase 1 study of AVO436 in acute myeloid leukemia and myelodysplastic syndrome patients) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) BIO-TECHNE Corp (NASDAQ: TECH ) BioLife Solutions Inc (NASDAQ: BLFS ) BioNTech SE – ADR (NASDAQ: BNTX ) - announced over 90% efficacy in the Phase 3 study of its coronavirus vaccine candidate co-developed with Pfizer Inc. (NYSE: PFE ) C4 Therapeutics Inc (NASDAQ: CCCC ) Calliditas Therapeutics Adr Rep 2 Ord Shs (NASDAQ: CALT ) (announced positive topline results from Part A of the Phase 3 clinical trial of Nefecon in patients with primary IgA nephropathy) Catalent Inc (NYSE: CTLT ) Denali Therapeutics Inc (NASDAQ: DNLI ) Fate Therapeutics Inc (NASDAQ: FATE ) Halozyme Therapeutics, Inc.
   The Daily Biotech Pulse: Alzheimer's Conference Underway, Biogen's Aducanumab Briefing Doc, Supernus Earnings  2020/11/04 13:21:27 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 3) Bio-Rad Laboratories, Inc. (NYSE: BIO ) Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN ) BioLife Solutions Inc (NASDAQ: BLFS ) BioLineRx ADR Representing 15 Ord Shs (NASDAQ: BLRX )(reacted to positive readout for its stem cell therapy to treat cancer) Halozyme Therapeutics, Inc. (NASDAQ: HALO )(reacted to its quarterly results) Idera Pharmaceuticals Inc (NASDAQ: IDRA ) Inspire Medical Systems Inc (NYSE: INSP ) ( reported strong results for the third quarter) Immunovant Inc (NASDAQ: IMVT ) Scholar Rock Holding Corp (NASDAQ: SRRK ) Ultragenyx Pharmaceutical Inc (NASDAQ: RARE ) United Therapeutics Corporation (NASDAQ: UTHR ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Nov. 3) Abeona Therapeutics Inc (NASDAQ: ABEO ) Aprea Therapeutics Inc (NASDAQ: APRE ) Bellicum Pharmaceuticals Inc (NASDAQ: BLCM ) Benitec Biopharma Inc (NASDAQ: BNTC ) Esperion Therapeutics Inc (NASDAQ: ESPR ) (reacted to its quarterly results) Happiness Biotech Group Ltd (NASDAQ: HAPP ) Jaguar Health Inc (NASDAQ: JAGX ) Liminal BioSciences Inc (NASDAQ: LMNL ) Nabriva Therapeutics PLC – ADR (NASDAQ: NBRV ) Neovasc Inc (NASDAQ: NVCN ) Opthea Spon (NASDAQ: OPT ) Silence Therapeutics ADR (NASDAQ: SLN ) Titan Pharmaceuticals, Inc (NASDAQ: TTNP ) Stocks In Focus Bristol-Myers Squibb Says Antitrust Waiting Period For Proposed Myokardia Acquisition Expires Bristol-Myers Squibb Co (NYSE: BMY ) said the waiting period under the HSR Act in connection with its previously announced tender offer to acquire …
   88 Biggest Movers From Friday  2021/02/01 09:07:57 Benzinga
Gainers Siebert Financial Corp. (NASDAQ: SIEB ) shares climbed 121.6% to close at $8.22 on Friday on heavy volume. Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB ) climbed 70.8% to close at $4.15 after the company announced the acquisition of Quellis Biosciences. GameStop Corp. (NYSE: GME ) shares added 67.9% to close at $325.00 after Robinhood said it would allow some buying of the stocks on Friday after sparking outrage over discontinuing purchases of GME, AMC, and high stocks seeing social media interest. The company’s stock dropped over 44% on Thursday. Novavax, Inc. (NASDAQ: NVAX ) surged 64.9% to close at $220.94 after the company said Thursday that its COVID-19 vaccine candidate NVX-COV2373 showed 89.3% efficacy in Phase 3 trials conducted in the United Kingdom. AMC Entertainment Holdings, Inc. (NYSE: AMC ) surged 53.7% to close at $13.26 after Robinhood said it would allow some buying of the stocks on Friday after sparking outrage over discontinuing purchases of GME, AMC, and high stocks seeing social media interest.
   Amid a record bad year, Bellicum keeps taking its lumps as FDA slams trial hold on CAR-T hopeful  2020/12/07 13:55:19 Endpoints News
It’s been no less than a disastrous year for Houston biotech Bellicum Pharmaceuticals after taking a scalpel to its pipeline and dumping a vast majority of its staff. Now, in an already-doomed trial of one of Bellicum’s next-gen oncology hopefuls, the FDA is doling out even more lumps. Bellicum divulged
   Recent Updates on Hemophagocytic Lymphohistiocytosis Market 2020-2027, Global Players are SOBI, AB2 Bio Ltd, Alpine Immune Sciences, Bellicum Pharmaceuticals  2020/11/18 12:21:10 OpenPR
Global Hemophagocytic Lymphohistiocytosis Market report brings into light key market dynamics of the sector. It provides guidelines about planning of advertising and sales promotion efforts. The market report is a professional yet exhaustive study on the current state for the
   The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies  2020/11/10 13:40:14 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 9) Alcon AG (NYSE: ALC ) Aligos Therapeutics Inc (NASDAQ: ALGS ) Aptevo Therapeutics Inc (NASDAQ: APVO ) (announced second complete remission in a patient in Cohort 6 of a Phase 1 study of AVO436 in acute myeloid leukemia and myelodysplastic syndrome patients) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) BIO-TECHNE Corp (NASDAQ: TECH ) BioLife Solutions Inc (NASDAQ: BLFS ) BioNTech SE – ADR (NASDAQ: BNTX ) - announced over 90% efficacy in the Phase 3 study of its coronavirus vaccine candidate co-developed with Pfizer Inc. (NYSE: PFE ) C4 Therapeutics Inc (NASDAQ: CCCC ) Calliditas Therapeutics Adr Rep 2 Ord Shs (NASDAQ: CALT ) (announced positive topline results from Part A of the Phase 3 clinical trial of Nefecon in patients with primary IgA nephropathy) Catalent Inc (NYSE: CTLT ) Denali Therapeutics Inc (NASDAQ: DNLI ) Fate Therapeutics Inc (NASDAQ: FATE ) Halozyme Therapeutics, Inc.
   The Daily Biotech Pulse: Alzheimer's Conference Underway, Biogen's Aducanumab Briefing Doc, Supernus Earnings  2020/11/04 13:21:27 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 3) Bio-Rad Laboratories, Inc. (NYSE: BIO ) Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN ) BioLife Solutions Inc (NASDAQ: BLFS ) BioLineRx ADR Representing 15 Ord Shs (NASDAQ: BLRX )(reacted to positive readout for its stem cell therapy to treat cancer) Halozyme Therapeutics, Inc. (NASDAQ: HALO )(reacted to its quarterly results) Idera Pharmaceuticals Inc (NASDAQ: IDRA ) Inspire Medical Systems Inc (NYSE: INSP ) ( reported strong results for the third quarter) Immunovant Inc (NASDAQ: IMVT ) Scholar Rock Holding Corp (NASDAQ: SRRK ) Ultragenyx Pharmaceutical Inc (NASDAQ: RARE ) United Therapeutics Corporation (NASDAQ: UTHR ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Nov. 3) Abeona Therapeutics Inc (NASDAQ: ABEO ) Aprea Therapeutics Inc (NASDAQ: APRE ) Bellicum Pharmaceuticals Inc (NASDAQ: BLCM ) Benitec Biopharma Inc (NASDAQ: BNTC ) Esperion Therapeutics Inc (NASDAQ: ESPR ) (reacted to its quarterly results) Happiness Biotech Group Ltd (NASDAQ: HAPP ) Jaguar Health Inc (NASDAQ: JAGX ) Liminal BioSciences Inc (NASDAQ: LMNL ) Nabriva Therapeutics PLC – ADR (NASDAQ: NBRV ) Neovasc Inc (NASDAQ: NVCN ) Opthea Spon (NASDAQ: OPT ) Silence Therapeutics ADR (NASDAQ: SLN ) Titan Pharmaceuticals, Inc (NASDAQ: TTNP ) Stocks In Focus Bristol-Myers Squibb Says Antitrust Waiting Period For Proposed Myokardia Acquisition Expires Bristol-Myers Squibb Co (NYSE: BMY ) said the waiting period under the HSR Act in connection with its previously announced tender offer to acquire …

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 ベリカム・ファ―マシュ―ティカルズ BLCM Bellicum Pharmaceuticals Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)